CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 14, 2012--
ARIAD
Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that its Annual
Meeting of Stockholders will be webcast live on June 21, 2012 and can be
accessed by visiting the investor relations section of the Company's
website at http://www.ariad.com/investor.
The annual meeting will take place at 10:00 a.m. (EDT) at the Company's
offices in Cambridge, Massachusetts and will include an overview of
ARIAD and its key programs provided by Harvey J. Berger, M.D., chairman
and chief executive officer of ARIAD, and key members of senior
management. A replay will be available on the investor page of the ARIAD
website approximately three hours after the presentation and will be
archived for four weeks. To ensure a timely connection to the live
webcast, participants should log on at least fifteen minutes prior to
the scheduled start time.
About ARIAD
ARIAD Pharmaceuticals, Inc. is an emerging global oncology company
focused on the discovery, development and commercialization of medicines
to transform the lives of cancer patients. ARIAD’s approach to
structure-based drug design has led to several internally discovered,
molecularly targeted product candidates for drug-resistant or
difficult-to-treat cancers, including certain forms of chronic myeloid
leukemia and non-small cell lung cancer. For additional information,
visit http://www.ariad.com
or follow ARIAD on Twitter
(@ARIADPharm).
Source: ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc.
For Investors
Maria E.
Cantor, 617-621-2208
Maria.cantor@ariad.com
or
For
Media
Lynn Granito, 212-253-8881
lgranito@berrypr.com
